All-cause mortality in 272 186 patients hospitalized with incident atrial fibrillation 1995-2008: a Swedish nationwide long-term case-control study

被引:331
作者
Andersson, Tommy [1 ]
Magnuson, Anders [2 ]
Bryngelsson, Ing-Liss [3 ]
Frobert, Ole [1 ]
Henriksson, Karin M. [4 ,5 ]
Edvardsson, Nils [6 ]
Poci, Dritan [1 ]
机构
[1] Orebro Univ Hosp, Dept Cardiol, S-70185 Orebro, Sweden
[2] Orebro Univ Hosp, Unit Clin Epidemiol & Biostat, S-70185 Orebro, Sweden
[3] Orebro Univ Hosp, Dept Occupat & Environm Med, S-70185 Orebro, Sweden
[4] Lund Univ, Dept Lab Med, Lund, Sweden
[5] AstraZeneca R&D, Molndal, Sweden
[6] Sahlgrens Univ Hosp, Sahlgrenska Acad, Gothenburg, Sweden
关键词
Atrial fibrillation; Mortality; Gender; Age; Long term; CHRONIC HEART-FAILURE; MYOCARDIAL-INFARCTION; PREDICTING STROKE; RISK-FACTOR; GUIDELINES; DIAGNOSIS; IMPACT; INTERVENTION; METAANALYSIS; PREVALENCE;
D O I
10.1093/eurheartj/ehs469
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To evaluate long-term all-cause risk of mortality in women and men hospitalized for the first time with atrial fibrillation (AF) compared with matched controls. Methods and results A total of 272 186 patients (44% women) <= 85 years at the time of hospitalization with incidental AF 1995-2008 and 544 344 matched controls free of in-hospital diagnosis of AF were identified. Patients were followed via record linkage of the Swedish National Patient Registry and the Cause of Death Registry. Using Cox regression models, the long-term relative all-cause mortality risk, adjusted for concomitant diseases, in women vs. controls was 2.15, 1.72, and 1.44 (P < 0.001) in the age categories <= 65, 65-74, and 75-85 years, respectively. The corresponding figures for men were 1.76, 1.36, and 1.24 (P < 0.001). Among concomitant diseases, neoplasm, chronic renal failure, and chronic obstructive pulmonary disease contributed most to the increased all-cause mortality vs. controls. In patients with AF as the primary diagnosis, the relative risk of mortality was 1.63, 1.46, and 1.28 (P < 0.001) in women and 1.45, 1.17, and 1.10 (P < 0.001) in men. Conclusion Atrial fibrillation was an independent risk factor of all-cause mortality in patients with incident AF. The concomitant diseases that contributed most were found outside the thromboembolic risk scores. The highest relative risk of mortality was seen in women and in the youngest patients compared with controls, and the differences between genders in each age category were statistically significant.
引用
收藏
页码:1061 / 1067
页数:7
相关论文
共 25 条
[1]   Impact of atrial fibrillation on the risk of death [J].
Benjamin, EJ ;
Wolf, PA ;
D'Agostino, RB ;
Silbershatz, H ;
Kannel, WB ;
Levy, D .
CIRCULATION, 1998, 98 (10) :946-952
[2]   Progression From Paroxysmal to Persistent Atrial Fibrillation Clinical Correlates and Prognosis [J].
de Vos, Cees B. ;
Pisters, Ron ;
Nieuwlaat, Robby ;
Prins, Martin H. ;
Tieleman, Robert G. ;
Coelen, Robert-Jan S. ;
van den Heijkant, Antonius C. ;
Allessie, Maurits A. ;
Crijns, Harry J. G. M. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (08) :725-731
[3]   Stroke prophylaxis in atrial fibrillation: who gets it and who does not? [J].
Friberg, Leif ;
Hammar, Niklas ;
Ringh, Mattias ;
Pettersson, Hans ;
Rosenqvist, Marten .
EUROPEAN HEART JOURNAL, 2006, 27 (16) :1954-1964
[4]   Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study [J].
Friberg, Leif ;
Benson, Lina ;
Rosenqvist, Marten ;
Lip, Gregory Y. H. .
BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
[5]   Decrease in mortality in patients with a hospital diagnosis of atrial fibrillation in Denmark during the period 1980-1993 [J].
Frost, L ;
Engholm, G ;
Moller, H ;
Husted, S .
EUROPEAN HEART JOURNAL, 1999, 20 (21) :1592-1599
[6]   Trends in incidence and mortality in the hospital diagnosis of atrial fibrillation or flutter in Denmark, 1980-1999 [J].
Frost, L ;
Vestergaard, P ;
Mosekilde, L ;
Mortensen, LS .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 103 (01) :78-84
[7]   Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation [J].
Gage, BF ;
Waterman, AD ;
Shannon, W ;
Boechler, M ;
Rich, MW ;
Radford, MJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (22) :2864-2870
[8]   Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation [J].
Hart, Robert G. ;
Pearce, Lesly A. ;
Aguilar, Maria I. .
ANNALS OF INTERNAL MEDICINE, 2007, 146 (12) :857-867
[9]   Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study [J].
Heeringa, J ;
van der Kuip, DAM ;
Hofman, A ;
Kors, JA ;
van Herpen, G ;
Stricker, BHC ;
Stijnen, T ;
Lip, GYH ;
Witteman, JCM .
EUROPEAN HEART JOURNAL, 2006, 27 (08) :949-953
[10]   Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation [J].
Hohnloser, Stefan H. ;
Crijns, Harry J. G. M. ;
van Eickels, Martin ;
Gaudin, Christophe ;
Page, Richard L. ;
Torp-Pedersen, Christian ;
Connolly, Stuart J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (07) :668-678